| Literature DB >> 29150318 |
Wei-Jun Wei1, Guo-Qiang Zhang2, Quan-Yong Luo3.
Abstract
Postsurgical management of differentiated thyroid cancer in China has gained a great success in the last twenty years, but there are still gaps to be filled. Here, we briefly review the current status and also extend an outlook for future development.Entities:
Keywords: immunotherapy; molecularly targeted therapy; radioiodine; state-of-the-art; thyroid cancer; tumor models
Mesh：
Substances：
Year: 2017 PMID： 29150318 DOI： 10.1016/j.tem.2017.10.008
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN： 1043-2760 Impact factor: 12.015